Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Surface Plasmon Resonance is a useful tool for studying protein interactions and has potential for future technological advancements.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Long-term minoxidil use can cause pseudoacromegaly, but stopping it improves symptoms.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Safflower (Carthamus tinctorius) extract helps hair grow and could be used in hair products.

Injection lipolysis effectively reduces small fat deposits and should be done with care and proper patient selection.

Higher BMI links to worse hair loss in Taiwanese men.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

Researchers created LabeledIn, a detailed list of drug uses, showing the importance of human input in making such lists.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

A study found that minoxidil can damage the hearts of dogs and pigs, cautioning its use in humans.

Some herbs show promise as antiandrogenic agents.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Cromakalim relaxes various blood vessels, while minoxidil sulphate is more selective; they likely act on different potassium channels.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.